Preclinical Feasibility and Patency Analyses of a New Distal Coronary Connector: The ELANA Heart Bypass
Stecher, David; Hoogewerf, Marieke; Bronkers, Glenn; van Putte, Bart P; Doevendans, Pieter A; Tulleken, Cornelis A F; van Herwerden, Lex; Pasterkamp, Gerard; Buijsrogge, Marc P
(2021) Innovations (Philadelphia, Pa.), volume 16, issue 2, pp. 163 - 168
(Article)
Abstract
Objective: This preclinical study determines the feasibility and 6-month patency rates of a new distal coronary connector, the Excimer Laser Assisted Nonocclusive Anastomosis (ELANA) Heart Bypass. Methods: Twenty Dutch Landrace pigs received either a hand-sewn (n = 8) or an ELANA (n = 12) left internal thoracic artery to left
... read more
anterior descending artery anastomosis, using off-pump coronary artery bypass grafting. Six-month patency rates were demonstrated by coronary angiography and histological evaluation. Throughout, procedural details and complication rates were collected. Results: The ELANA Heart Bypass demonstrated 0% mortality and complication rates during follow-up. It was demonstrated feasible, with comparable perioperative flow measurements (ELANA vs hand-sewn, median [min to max], 24 [14 to 28] vs 17 [12 to 31] mL/min; P = 0.601) and fast construction times (3 [3 to 7] vs 31 [26 to 37] min; P < 0.001). Yet, an extra hemostatic stitch was needed in 25% of the ELANA versus 12.5% of the hand-sewn anastomoses. The 6-month patency rate of the ELANA Heart Bypass was 83.3% versus 100% in hand-sewn anastomoses. The 2 occluded ELANA-anastomoses were defined model-based errors. Conclusions: The ELANA Heart Bypass facilitates a sutureless distal coronary anastomosis. A design change is suggested to improve hemostasis and will be evaluated in future translational studies. This new technique is a potential alternative to hand-sewn anastomoses in (minimally invasive) coronary surgery.
show less
Download/Full Text
Keywords: coronary artery bypass grafting, coronary connector, coronary revascularization, OPCAB, sutureless anastomosis, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, Journal Article
ISSN: 1556-9845
Publisher: Lippincott Williams & Wilkins
Note: Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: This research was financially supported by the University Medical Center Utrecht and Corvasco Medical B.V. (the former company developing the ELANA Heart Bypass). David Stecher, Glenn Bronkers, and Cornelis A.F. Tulleken are registered as co-inventors of patents regarding the ELANA technique, without financial benefits. Cornelis A.F. Tulleken is founder of the ELANA technique. Marieke Hoogewerf and Glenn Bronkers are currently employed by AMT Medical Research B.V. All authors declare no competing financial interests and have nothing to disclose with regard to commercial support. The authors have performed a free and independent evaluation of this new technology and had full control of the design of the study, methods used, outcome parameters, analysis of data, and production of the written report. Funding Information: We acknowledge the constructive contributions of Martijn van Nieuwburg, Evelyn Velema, Grace Croft, Joyce Visser, Marlijn Jansen, Cees Verlaan, and colleagues from the Utrecht University Central Animal Facilities for their support and care for the animals and experiments; Noortje van den Dungen, Arjen Schoneveld, and Petra van der Kraak for their support for processing the samples for histology; and Niklank Noest, Rik Mansvelt Beck, Sander van Thoor, and other colleagues of Corvasco Medical and ELANA B.V., and the Brain Technology Institute, for their technical support. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the EuroTransBio grant (ETB110014). Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the EuroTransBio grant (ETB110014). Publisher Copyright: © The Author(s) 2021.
(Peer reviewed)